ALMDP.PA
Price:
$0.35
Market Cap:
$1.80M
Medesis Pharma S.A., a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. Its products include NanoLithium (NP03), a clinical stage development product for the treatment of Alzheimer's disease; NanosiRNA DH for the treatment of Huntington's Disease; NU01 Plutonium and NU02 Cesium decorporation products for nuclear decorporation; a radioprotection drug to treat people irradiated following a civil or military nuclear accident (NP02 NanoManganese); NanosiRNA COVID-19, an antiviral treatment solution for viral diseases; and NanosiRNA Resistant cancers and NanosiRNA Oncolytic virus for ...[Read more]
Industry
Biotechnology
IPO Date
2021-02-12
Stock Exchange
PAR
Ticker
ALMDP.PA
According to Medesis Pharma S.A.’s latest financial reports and current stock price. The company's current ROE is 40.07%. This represents a change of 137.12% compared to the average of 16.90% of the last 4 quarters.
The mean historical ROE of Medesis Pharma S.A. over the last ten years is 65.04%. The current 40.07% ROE has changed -38.40% with respect to the historical average. Over the past ten years (40 quarters), ALMDP.PA's ROE was at its highest in in the September 2022 quarter at 55.51%. The ROE was at its lowest in in the March 2022 quarter at -675.03%.
Average
65.04%
Median
66.31%
Minimum
-160.89%
Maximum
261.20%
Discovering the peaks and valleys of Medesis Pharma S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 261.20%
Minimum Annual Increase = -495.58%
Minimum Annual ROE = -160.89%
Year | ROE | Change |
---|---|---|
2023 | 87.99% | -66.31% |
2022 | 261.20% | -262.34% |
2021 | -160.89% | -495.58% |
2020 | 40.67% | -8.85% |
2019 | 44.62% | -61.75% |
The current ROE of Medesis Pharma S.A. (ALMDP.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
62.77%
5-year avg
54.72%
10-year avg
65.04%
Medesis Pharma S.A.’s ROE is greater than Pherecydes Pharma S.A. (-64.06%), greater than Hydrogen-Refueling-Solutions S.A. (-19.47%), less than OSE Immunotherapeutics S.A. (51.56%), less than Biophytis S.A. (188.15%), greater than Abivax S.A. (-211.00%),
Company | ROE | Market cap |
---|---|---|
-64.06% | $15.83M | |
-19.47% | $52.18M | |
51.56% | $115.94M | |
188.15% | $2.90M | |
-211.00% | $451.16M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Medesis Pharma S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Medesis Pharma S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Medesis Pharma S.A.'s ROE?
How is the ROE calculated for Medesis Pharma S.A. (ALMDP.PA)?
What is the highest ROE for Medesis Pharma S.A. (ALMDP.PA)?
What is the 3-year average ROE for Medesis Pharma S.A. (ALMDP.PA)?
What is the 5-year average ROE for Medesis Pharma S.A. (ALMDP.PA)?
How does the current ROE for Medesis Pharma S.A. (ALMDP.PA) compare to its historical average?